You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.


Test Information
Home / Tests / Critical Infectious Diseases / Xpert Xpress SARS-CoV-2/Flu/RSV

Xpert® Xpress SARS-CoV-2/Flu/RSV

Actionable rapid respiratory results to meet the challenges of the ongoing pandemic.

Xpert<sup>®&nbsp;</sup>Xpress SARS-CoV-2/Flu/RSV

The Need

  • Detection and differentiation of flu, RSV, and COVID-19 which all present with similar symptoms
  • Insights for effective triage and patient management
  • Risk assessment for patients and staff while resuming traditional healthcare procedures
  • Identify potential cases of co-infections during respiratory season
  • Current flu and SARS-CoV-2 therapies need definitive diagnosis for each pathogen

The Solution

  • Actionable detection of SARS-CoV-2, Flu A, Flu B, and RSV in as little as 25 minutes^
  • Actionable on-demand results with 1 sample collection
  • Optimizes GeneXpert® System module capacity by combining 2 Xpress tests into 1
  • Standardization of results between the central lab and near patient testing sites

The Impact

  • Empower patients with rapid results to help keep their loved ones and the community safe
  • Assist hospitals to effectively manage limited resources
  • Provide labs with single-test confidence to accelerate workflows
  • Support clinicians with on-demand, timely, and accurate results

*For Use Under an Emergency Use Authorization (EAU) only. This test has not been FDA cleared or approved; this test has been authorized by FDA under an EUA for use by authorized laboratories; this test has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV), and not for any other viruses or pathogens; and this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

^ For positives when running SARS-CoV-2 only on Xpress SARS-CoV-2/Flu/RSV; otherwise, the test will have a runtime of approximately 36 minutes.

CE-IVD In Vitro Diagnostic Medical Device. Not available in all countries.

Ordering Info

Xpert® Xpress SARS-CoV-2/Flu/RSV

Number of tests: 10

Catalog #: XPCOV2/FLU/RSV-10
Back to Top